$96.1 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 24 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 75.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VT | Sell | VANGUARD TOTAL WORLD STOCK ETFetfs | $14,637,000 | +7.8% | 181,506 | -0.0% | 15.24% | -71.0% |
SQ | Exit | SQUARE INC | $0 | – | -500 | -100.0% | -0.20% | – |
SYK | Exit | STRYKER CORP | $0 | – | -3,800 | -100.0% | -2.65% | – |
AMGN | Exit | AMGEN INC | $0 | – | -3,615 | -100.0% | -3.30% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TEXAS INSTRUMENTS INC | 44 | Q2 2024 | 31.2% |
PORTLAND GENERAL ELECTRIC CO | 41 | Q2 2024 | 0.0% |
LEXICON PHARMACEUTICALS INC | 36 | Q2 2024 | 1.7% |
AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AILERON THERAPEUTICS INC | March 05, 2024 | 1,812,627 | 6.2% |
Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-09-17 |
N-PX | 2024-09-03 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR/A | 2024-08-29 |
13F-HR | 2024-08-01 |
4 | 2024-06-17 |
4 | 2024-06-12 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.